Serological paroteomic biomarkers for monitoring liver fibrosis regression in on-treatment hepatities b patients

Paired serological proteomes from CHB patients undergoing short-term and long-term anti-viral treatment were profiled using PRM-based proteomics technology.The serological proteomic landscapes following AVT were systematically analyzed and compared between fibrosis regressors and non-regressors.